Literature DB >> 399592

Sympathetic reflex responses during treatment of essential hypertension with hydrallazine and oxprenolol.

I B Davies, P S Sever, T Rosenthal.   

Abstract

1. The short term effects of hydrallazine, oxprenolol and oxprenolol plus hydrallazine were studied in five patients with essential hypertension. 2. The increase in pulse rate caused by hydrallazine was prevented by combined treatment with oxprenolol, which also lowered the high plasma noradrenaline levels, associated with the use of hydrallazine. 3. Plasma renin activity was higher in the supine and standing positions with hydrallazine than with oxprenolol alone and with the patients standing this high renin level was prevented by simultaneous treatment with oxprenolol. With the patients supine, combination of oxprenolol with hydrallazine resulted in a mean plasma renin activity which was less than half that with hydrallazine alone, although this difference was not statistically significant. 4. The combination of oxprenolol with hydrallazine did not lower the blood pressure further, but reduced the increased sympathetic activity which occurred with hydrallazine alone.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 399592      PMCID: PMC1429708          DOI: 10.1111/j.1365-2125.1979.tb05908.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Long term beta-adrenergic blockade reduces tyrosine hydroxylase and dopamine beta-hydroxylase activities in sympathetic ganglia.

Authors:  A E Raine; I W Chubb
Journal:  Nature       Date:  1977-05-19       Impact factor: 49.962

2.  Hemodynamic effects of 1-hydrazinophthalazine in patients with arterial hypertension.

Authors:  G G ROWE; J H HUSTON; G M MAXWELL; A P CROSLEY; C W CRUMPTON
Journal:  J Clin Invest       Date:  1955-01       Impact factor: 14.808

3.  The hemodynamic effects of hypotensive drugs in man. IV. 1-Hydrazinophthalazine.

Authors:  E D FREIS; J C ROSE; T F HIGGINS; F A FINNERTY; R T KELLEY; E A PARTENOPE
Journal:  Circulation       Date:  1953-08       Impact factor: 29.690

4.  Radioimmunoassay determination of plasma-renin activity.

Authors:  G W Boyd; A E Fitz; A R Adamson; W S Peart
Journal:  Lancet       Date:  1969-02-01       Impact factor: 79.321

5.  Observation on the mechanism of renin release by hydralazine in hypertensive patients.

Authors:  H Ueda; Y Kaneko; T Takeda; T Ikeda; S Yagi
Journal:  Circ Res       Date:  1970-10       Impact factor: 17.367

6.  Are racial differences in essential hypertension due to different pathogenetic mechanisms?

Authors:  P S Sever; W S Peart; T W Meade; I B Davies; D Gordon; R D Tunbridge
Journal:  Clin Sci Mol Med Suppl       Date:  1978-12

7.  Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension.

Authors:  J W Hollifield; K Sherman; R V Zwagg; D G Shand
Journal:  N Engl J Med       Date:  1976-07-08       Impact factor: 91.245

8.  Effect of alprenolol and hydralazine on plasma renin concentration in patients with arterial hypertension.

Authors:  E B Pedersen; H J Kornerup
Journal:  Acta Med Scand       Date:  1975-11

9.  Plasma-noradrenaline in essential hypertension.

Authors:  P S Sever; B Osikowska; M Birch; R D Tunbridge
Journal:  Lancet       Date:  1977-05-21       Impact factor: 79.321

10.  Is the adrenergic control of renin release dominant in man?

Authors:  R Davies; J D Slater
Journal:  Lancet       Date:  1976-09-18       Impact factor: 79.321

View more
  4 in total

1.  Hydrallazine as an aphrodisiac?

Authors:  I B Davies
Journal:  Br Med J       Date:  1979-11-24

2.  Cardiovascular effects of alinidine and propranolol alone and in combination with hydralazine in normal man.

Authors:  D P Nicholls; D W Harron; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

3.  Differential blockade of alpha-adrenoceptors by indoramin.

Authors:  D P Nicholls; P C O'Connor; D W Harron; W J Leahey; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

4.  Effects of indomethacin and (+/-)-propranolol on the cardiovascular and renin responses to vasoactive intestinal polypeptide (VIP) infusion in man.

Authors:  R J Unwin; T Reed; S Thom; J Calam; W S Peart
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.